TIG Advisors, LLC

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1358253 New York, NY

Back to APLS Full portfolio

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

1,252,986

+7230.4% QoQ

Ownership

0.979%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Derivatives in APLS

reported options exposure · as of Dec 31, 2023

CallValue

CallShares

156,100

PutValue

PutShares

53,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TIG Advisors, LLC holds $115,400,384 across 4 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	TECH	BIO-TECHNE Corp	842,192	$59,500,864
2	APGE	Apogee Therapeutics, Inc.	364,250	$48,346,902
3	RNA	Atrium Therapeutics, Inc.	561,533	$7,552,618
4	NUVL	Nuvalent, Inc.	63,055	$0

All Filings in APLS

Export CSV

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	—	1,252,986	+7230.4%	Shares	Sole	2026-05-15
2023-12-31	—	53,400	—	Put	Sole	2024-02-14
2023-12-31	—	156,100	—	Call	Sole	2024-02-14
2023-12-31	—	17,093	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.